Glucomannan (Konjac Root Fiber)

Amorphophallus konjac
Evidence Level
Strong
2 Clinical Trials
4 Documented Benefits
4/5 Evidence Score

Glucomannan is a water-soluble dietary fiber derived from the root of the konjac plant (Amorphophallus konjac), with the highest viscosity and water-absorption capacity of any known dietary fiber — absorbing up to 50 times its weight in water and forming an extremely thick gel in the stomach. This exceptional gel-forming ability makes glucomannan one of the most effective natural appetite suppressants and cholesterol-lowering agents, with FDA-qualified health claims for blood sugar and cholesterol management in some jurisdictions.

Studied Dose 3–4 g/day before meals (1 g three times daily, 30 minutes before meals with 250 mL water); always take with large amount of water — esophageal obstruction risk if taken dry
Active Compound Konjac glucomannan (KGM) — high molecular weight (200,000–2,000,000 Da) beta-1,4-linked mannose and glucose polysaccharide; molecular weight critical for viscosity and efficacy

Benefits

Weight loss and appetite suppression

A meta-analysis of 14 RCTs confirms glucomannan supplementation produces significant reductions in body weight (approximately 0.79 kg over 5 weeks), body fat, and BMI vs. placebo — through its exceptional appetite-suppressing, gastric emptying-slowing, and caloric displacement effects. The extreme viscosity of konjac gel produces greater and longer-lasting satiety than other fiber types at equivalent doses.

Cholesterol and LDL reduction

Meta-analyses of multiple RCTs confirm glucomannan significantly reduces total cholesterol (by ~19 mg/dL) and LDL cholesterol (by ~16 mg/dL) — effects comparable to modest statin therapy for mild hypercholesterolemia. The mechanism involves bile acid sequestration, reduced intestinal cholesterol absorption, and increased hepatic LDL receptor expression from bile acid pool depletion.

Blood sugar and diabetes management

Glucomannan's extreme gel viscosity dramatically reduces the rate of glucose absorption from mixed meals, producing significant blunting of postprandial glucose and insulin spikes. Meta-analyses confirm consistent reductions in fasting glucose, postprandial glucose, and HbA1c in diabetic and pre-diabetic patients — with the FDA recognizing a qualified health claim for diabetes risk reduction.

Prebiotic and gut health benefits

Glucomannan is selectively fermented by beneficial gut bacteria — particularly Bifidobacterium and Lactobacillus — producing short-chain fatty acids that feed colonocytes, reduce colonic inflammation, and improve gut barrier integrity. This prebiotic effect complements glucomannan's direct physical effects for comprehensive digestive health support.

Mechanism of action

1

Extreme gel viscosity and gastric emptying delay

Glucomannan absorbs 50× its weight in water, forming the most viscous food-grade gel known — with viscosity values 10–100× greater than other common dietary fibers at equivalent concentrations. This gel dramatically increases the viscosity of GI contents, slowing gastric emptying, reducing nutrient absorption rates, and extending satiety signals from gastric stretch receptors and satiety hormones.

2

Bile acid sequestration and cholesterol reduction

The highly viscous glucomannan gel physically entraps bile acids in the small intestinal lumen, preventing their reabsorption into the enterohepatic circulation. The liver must convert additional cholesterol to bile acids to replace the excreted pool, reducing hepatic cholesterol and upregulating LDL receptors on hepatocytes — producing the consistent LDL reductions observed in clinical trials.

3

Gut hormone stimulation for appetite regulation

Glucomannan-induced gastric distension and intestinal fermentation stimulate release of GLP-1, PYY, and CCK from enteroendocrine cells — producing sustained satiety hormone elevations that reduce food intake at subsequent meals. This neuroendocrine satiety mechanism operates in addition to the physical gastric filling effect.

Clinical trials

1
Glucomannan and Weight Loss — Evidence Synthesis

Evidence review and pooled analysis of randomized controlled trials examining glucomannan supplementation for weight loss. (Am J Clin Nutr — earlier; also relevant)

Pooled across multiple clinical trials.

Glucomannan produced statistically significant but clinically modest reductions in body weight (~0.79 kg), LDL cholesterol, fasting glucose, and triglycerides vs placebo. Effect sizes small in absolute terms — glucomannan is not a meaningful weight loss intervention. The 2015 Cochrane-style update by Zalewski found NO significant weight loss effect when restricted to high-quality trials only.

2
Glucomannan and Lipid Profile — Evidence Synthesis

Pooled analysis of clinical trials examining glucomannan effects on cholesterol and lipid parameters. (Am J Clin Nutr — same source as weight)

Pooled across clinical trials.

Glucomannan reduced total cholesterol (~19 mg/dL), LDL (~16 mg/dL), and triglycerides (~11 mg/dL) vs placebo. Effects driven by soluble fiber binding bile acids (similar mechanism to oat beta-glucan and psyllium). FDA-approved health claim for soluble fiber and heart disease applies. Lipid effects more clinically relevant than weight loss effects.

Side effects and drug interactions

Common Potential side effects

Important: Always take with at least 250 mL (8 oz) water — tablets can expand in esophagus causing obstruction before reaching stomach; powder or capsule forms safer
Bloating, flatulence, and abdominal discomfort initially — start with lower doses and increase gradually
Loose stools or diarrhea at high doses
Glucomannan tablets have been associated with rare esophageal and intestinal obstruction cases

Important Drug interactions

ALL oral medications — glucomannan significantly slows absorption; take all medications at least 1 hour before or 4 hours after glucomannan to ensure proper drug absorption
Antidiabetic medications — significant additive glucose-lowering; serious hypoglycemia risk if combined with insulin or sulfonylureas; monitor blood sugar carefully
Cholesterol medications — additive LDL-lowering effects; generally beneficial; monitor lipid panel

Frequently asked questions about Glucomannan (Konjac Root Fiber)

How much glucomannan should I take?

Studies for appetite and weight use about 1 gram three times daily (3 grams total), taken with a large glass of water 15 to 30 minutes before meals. Always take it with plenty of liquid.

What is glucomannan used for?

Glucomannan is a highly absorbent soluble fiber from konjac root, used for appetite control and weight management (it expands in the stomach to promote fullness), supporting healthy cholesterol, and digestive regularity.

How do I take glucomannan safely?

Always take it with a full glass of water and never dry, because it swells dramatically and can cause choking or blockage in the throat or esophagus. Take it separately from medications, since it can reduce their absorption.

Does glucomannan have side effects?

The most common effects are gas, bloating, and loose stools, which often ease over time. The main safety concern is taking it with too little water. People with swallowing difficulties should avoid the powder or capsules.

What is Glucomannan?

Glucomannan is a water-soluble dietary fiber derived from the root of the konjac plant (Amorphophallus konjac), with the highest viscosity and water-absorption capacity of any known dietary fiber — absorbing up to 50 times its weight in water and forming an extremely thick gel in the stomach.

What is the recommended dosage of Glucomannan?

The clinically studied dose is 3–4 g/day before meals (1 g three times daily, 30 minutes before meals with 250 mL water); always take with large amount of water — esophageal obstruction risk if taken dry Always follow the product label and check with a healthcare provider for personal advice.

Is Glucomannan safe, and does it have side effects?

For most healthy adults, Glucomannan is well tolerated at studied doses. Reported effects can include: Important: Always take with at least 250 mL (8 oz) water — tablets can expand in esophagus causing obstruction before reaching stomach; powder or capsule forms safer Bloating, flatulence, and abdominal discomfort initially — start with lower doses and increase gradually It may also interact with some medications. Glucomannan is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Glucomannan interact with any medications?

Possible interactions include: ALL oral medications — glucomannan significantly slows absorption; take all medications at least 1 hour before or 4 hours after glucomannan to ensure proper drug absorption Antidiabetic medications — significant additive glucose-lowering; serious hypoglycemia risk if combined wit… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Glucomannan?

NutraSmarts rates the evidence for Glucomannan as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr. 2008;88(4):1167-75. doi: 10.1093/ajcn/88.4.1167.PubMedUsed to support: Backs the LDL, glycemic, and (modest) weight claims. Meta-analysis of 14 RCTs found glucomannan significantly lowered total and LDL cholesterol, triglycerides, fasting glucose, and body weight. Honest framing: the weight effect was small (about 0.8 kg) and it did not lower blood pressure.
  2. Ho HVT, Jovanovski E, Zurbau A, Blanco Mejia S, Sievenpiper JL, Au-Yeung F, Jenkins AL, Duvnjak L, Leiter L, Vuksan V. A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B. Am J Clin Nutr. 2017;105(5):1239-1247. doi: 10.3945/ajcn.116.142158.PubMedUsed to support: Strongest support for the LDL-cholesterol claim. Pooled 12 RCTs; about 3 g/day konjac glucomannan lowered LDL cholesterol by about 10% and non-HDL cholesterol by about 7% versus control (no significant change in apolipoprotein B). The cholesterol effect is the most solid benefit of glucomannan.
  3. Keithley JK, Swanson B, Mikolaitis SL, DeMeo M, Zeller JM, Fogg L, Adamji J. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults. J Obes. 2013;2013:610908. doi: 10.1155/2013/610908.PubMedUsed to support: Included for honesty on the weight claim - this RCT was essentially negative. In 53 overweight/obese adults, 8 weeks of glucomannan (about 4 g/day) was well tolerated but did not produce weight loss or change body composition, appetite, or lipid/glucose parameters versus placebo. Illustrates that the weight-loss evidence is mixed and often null.
  4. Vuksan V, Sievenpiper JL, Owen R, Swilley JA, Spadafora P, Jenkins DJ, Vidgen E, Brighenti F, Josse RG, Leiter LA, et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care. 2000;23(1):9-14. doi: 10.2337/diacare.23.1.9.PubMedUsed to support: Backs the glycemic-control and lipid claims. In this randomized controlled metabolic trial in adults with insulin resistance syndrome, konjac-mannan fiber improved glycemic control and lowered total and LDL cholesterol versus control, supporting metabolic/cardiometabolic benefits of the viscous fiber.